Pharmacokinetics and dialysability of is
✍
K. Schönholzer; C. Marone
📂
Article
📅
1992
🏛
Springer
🌐
English
⚖ 258 KB
The pharmacokinetics of isradipine, a calcium-channel blocker, have been studied in eight patients on chronic haemodialysis. A single oral dose of 5 mg was administered on both a non-haemodialysis and a haemodialysis day and the plasma concentrations of isradipine were analyzed. The mean cmax, tmax,